BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35262203)

  • 1. Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer.
    Rettig EM; Faden DL; Sandhu S; Wong K; Faquin WC; Warinner C; Stephens P; Kumar S; Kuperwasser C; Richmon JD; Uppaluri R; Varvares M; Sethi R; Hanna GJ; Sroussi H
    Int J Cancer; 2022 Oct; 151(7):1081-1085. PubMed ID: 35262203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Tumor HPV DNA in Patients With Head and Neck Carcinoma: Correlation With HPV Genotyping.
    Mijares K; Ferrandino R; Chai R; Roof S; Bhardwaj S; Posner M; Westra WH
    Am J Surg Pathol; 2024 Jan; 48(1):80-87. PubMed ID: 37753709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
    Batool S; Sethi RKV; Wang A; Dabekaussen K; Egloff AM; Del Vecchio Fitz C; Kuperwasser C; Uppaluri R; Shin J; Rettig EM
    Oral Oncol; 2023 Dec; 147():106584. PubMed ID: 37837735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck.
    Tanaka H; Takemoto N; Horie M; Takai E; Fukusumi T; Suzuki M; Eguchi H; Komukai S; Tatsumi M; Isohashi F; Ogawa K; Yachida S; Inohara H
    Int J Cancer; 2021 Feb; 148(4):995-1005. PubMed ID: 32895945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
    Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
    J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
    Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
    Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
    Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
    Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of blood-based biomarker testing in HPV-mediated head and neck squamous cell carcinoma.
    Haring CT; Rocco JW
    Cancer Cytopathol; 2024 Jan; 132(1):7-9. PubMed ID: 37350366
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
    Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
    Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.
    Naegele S; Efthymiou V; Hirayama S; Zhao BY; Das D; Chan AW; Richmon JD; Iafrate AJ; Faden DL
    Head Neck; 2023 Jun; 45(6):E25-E30. PubMed ID: 37080924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
    Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
    Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
    Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.
    Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q
    Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of high-risk HPV status of head and neck squamous cell carcinoma using the Roche cobas HPV test on cytologic specimens and acellular supernatant fluid.
    Wright MF; Weiss VL; Lewis JS; Schmitz JE; Ely KA
    Cancer Cytopathol; 2020 Jul; 128(7):482-490. PubMed ID: 32129949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
    Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
    J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.
    Berger BM; Hanna GJ; Posner MR; Genden EM; Lautersztain J; Naber SP; Del Vecchio Fitz C; Kuperwasser C
    Clin Cancer Res; 2022 Oct; 28(19):4292-4301. PubMed ID: 35576437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.
    Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.